Back
Xylem Vs. Akero Therapeutics Industry Stock Comparison
Buy
54
XYL
Xylem
Last Price:
130.54
Seasonality Move:
2.5%
Sell
25
AKRO
Akero Therapeutics
Last Price:
18.92
Seasonality Move:
16.15%
Buy
54
Xylem (XYL)
is a Buy
Is Xylem a Buy, Sell or Hold?
- The current Xylem [XYL] share price is $130.67. The Score for XYL is 54, which is 8% above its historic median score of 50, and infers lower risk than normal.
- XYL is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
25
Akero Therapeutics (AKRO)
is a Sell
Is Akero Therapeutics a Buy, Sell or Hold?
- The current Akero Therapeutics [AKRO] share price is $20.26. The Score for AKRO is 25, which is 50% below its historic median score of 50, and infers higher risk than normal.
- AKRO is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
XYL Stock Price Chart
AKRO Stock Price Chart
What is Akero Therapeutics's stock price today?
-
The Akero Therapeutics share price today is $20.26
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and AKRO is experiencing selling pressure, which indicates risk of future bearish movement.
XYL Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.68 | Buy |
| Relative Strength Index (14 RSI): | 61.77 | Buy |
| Chaikin Money Flow: | -186760 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (127.44 - 129.52) | Buy |
| Bollinger Bands (100): | (111.64 - 128) | Buy |
AKRO Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -1.21 | Sell |
| Relative Strength Index (14 RSI): | 31.81 | Sell |
| Chaikin Money Flow: | -465905 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (21.28 - 24.52) | Sell |
| Bollinger Bands (100): | (20 - 26.08) | Sell |
XYL Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 128.36 | Buy |
| 20-day SMA: | 128.42 | Buy |
| 50-day SMA: | 127.29 | Buy |
| 200-day SMA: | 109.56 | Buy |
| 8-day EMA: | 129.02 | Buy |
| 20-day EMA: | 128.37 | Buy |
| 50-day EMA: | 125.81 | Buy |
| 200-day EMA: | 113.99 | Buy |
AKRO Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 21.06 | Sell |
| 20-day SMA: | 22.39 | Sell |
| 50-day SMA: | 24.65 | Sell |
| 200-day SMA: | 29.08 | Sell |
| 8-day EMA: | 21.09 | Sell |
| 20-day EMA: | 22.3 | Sell |
| 50-day EMA: | 23.39 | Sell |
| 200-day EMA: | 27.61 | Sell |
Xylem Earnings Growth & XYL Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.23 per share, a decrease next quarter of $0.17 per share, an increase this year of $0.40 per share, and an increase next year of $0.53 per share.
Akero Therapeutics Earnings Growth & AKRO Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.32 per share, a decrease next quarter of $0.19 per share, a decrease this year of $1.01 per share, and a decrease next year of $0.65 per share.
Xylem Technical Analysis
| Apr 11 | Apr 12 | Apr 15 | Apr 16 | Apr 17 | Apr 18 | Apr 19 | Apr 22 | Apr 23 | Apr 24 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr | ||||||||||
| 11 | 12 | 15 | 16 | 17 | 18 | 19 | 22 | 23 | 24 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Akero Therapeutics Technical Analysis
| Apr 11 | Apr 12 | Apr 15 | Apr 16 | Apr 17 | Apr 18 | Apr 19 | Apr 22 | Apr 23 | Apr 24 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr | ||||||||||
| 11 | 12 | 15 | 16 | 17 | 18 | 19 | 22 | 23 | 24 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||